InsiderClue
Insiders · Profile

GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT at Theravance Biopharma. Filing since 14 Dec 2020. CIK 0001820036

Company
Date
Role
Action
Shares
Amount
Of holding
TBPH Theravance Biopharma, Inc.
14 Nov 2023
SVP, RESEARCH & DEVELOPMENT
Sold on a plan
2,482
$25.37K
0.7%
TBPH Theravance Biopharma, Inc.
16 Oct 2023
SVP, RESEARCH & DEVELOPMENT
Sold on a plan
2,482
$22.41K
0.7%
TBPH Theravance Biopharma, Inc.
14 Sep 2023
SVP, RESEARCH & DEVELOPMENT
Sold on a plan
2,482
$24.55K
0.7%
TBPH Theravance Biopharma, Inc.
11 Aug 2023
SVP, RESEARCH & DEVELOPMENT
Sold on a plan
2,322
$23.20K
0.7%
TBPH Theravance Biopharma, Inc.
14 Jul 2023
SVP, RESEARCH & DEVELOPMENT
Sold at will
2,322
$22.85K
0.7%
TBPH Theravance Biopharma, Inc.
14 Jun 2023
SVP, RESEARCH & DEVELOPMENT
Sold at will
2,322
$24.82K
0.7%
TBPH Theravance Biopharma, Inc.
15 May 2023
SVP, RESEARCH & DEVELOPMENT
Sold at will
2,322
$26.15K
0.6%
TBPH Theravance Biopharma, Inc.
14 Apr 2023
SVP, RESEARCH & DEVELOPMENT
Sold at will
2,323
$27.60K
0.6%
TBPH Theravance Biopharma, Inc.
14 Mar 2023
SVP, RESEARCH & DEVELOPMENT
Sold, plan not stated
2,323
$23.97K
0.6%
TBPH Theravance Biopharma, Inc.
6 Mar 2023
SVP, RESEARCH & DEVELOPMENT
Sold, plan not stated
2,323
$23.35K
0.6%
TBPH Theravance Biopharma, Inc.
1 Dec 2022
SVP, RESEARCH & DEVELOPMENT
Sold, plan not stated
2,084
$22.36K
0.7%
TBPH Theravance Biopharma, Inc.
16 Aug 2022
SVP, DEVELOPMENT
Sold, plan not stated
4,906
$47.64K
1.3%
TBPH Theravance Biopharma, Inc.
9 Aug 2022
SVP, DEVELOPMENT
Sold, plan not stated
15,086
$132.61K
3.9%
TBPH Theravance Biopharma, Inc.
14 Dec 2020
SVP, Development
Sold, plan not stated
7,500
$146.06K
5.7%
14 decisions on file.